|
|
||||||||
Department of Radiology, Washington University School of Medicine, St. Louis, Missouri
MURR University of Missouri, Columbia, Missouri
School of Pharmacy, Purdue University, West Lafayette, Indiana
Correspondence: For reprints contact: Carla J. Mathias, Washington University, The Edward Mallinckrodt Institution of Radiology, 510 S. Kingshighway, St. Louis, MO 63110.
ABSTRACT
Copper(II) pyruvaldehyde bis(N4-methylthiosemicarbazone) (Cu-PTSM), copper(II) pyruvaldehyde bis(N4-dimethylthiosemicarbazone) (Cu-PTSM2), and copper(II) ethylglyoxal bis(N4-methylthiosemicarbazone) (Cu-ETSM), have been proposed as PET tracers for cerebral blood flow (CBF) when labeled with generator-produced 62Cu (t1/2 = 9.7 mm) (1). To evaluate the potential of Cu-PTSM for CBF PET studies, baboon single-pass cerebral extraction measurements and PET imaging were earned out with the use of 67Cu(t1/2 = 2.6 days) and 64Cu (t1/2 = 12.7 hr), respectively (1). All three chelates were extracted into the brain with high efficiency. There was some clearance of all chelates in the 1050-sec time frame and Cu-PTSM2 continued to clear. Cu-PTSM and Cu-ETSM have high residual brain activity. PET imaging of baboon brain was carried out with the use of [64Cu]-Cu-PTSM. For comparison with the 64Cu brain image, a CBF (15O-labeled water) image (40 sec) was first obtained. Qualitatively, the H215O and [64Cu]-Cu-PTSM images were very similar; for example, a comparison of gray to white matter uptake resulted in ratios of 2.42 for H215O and 2.67 for Cu-PTSM. No redistribution of 64Cu was observed in 2 hr of imaging, as was predicted from the single-pass study results. Quantitative determination of blood flow using Cu-PTSM showed good agreement with blood flow determined with H215O. This data suggests that [62Cu]-Cu-PTSM may be a useful generator-produced radiopharmaceutical for blood flow studies with PET.
This article has been cited by other articles:
![]() |
K. Takakura, S. Yaguchi, Y. Kanansugi, K. Kobayashi, R. Okayasu, and Y. Fujibayashi Enhancement of chromosomal aberrations in tumor cells with a non-labeled Cu-PTSM and irradiation with Cu K-shell monochromatic X rays Radiat Prot Dosimetry, December 1, 2006; 122(1-4): 188 - 194. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |